Cell and Gene Commercialization

  1. Maximizing Impact: Strategies For Building Robust Patient Support Programs 6/12/2025

    Panelists explore the entire patient journey, from diagnosis to treatment, sharing strategies for creating practical, seamless support systems that ensure access to innovative cell and gene therapies.

  2. The Power Of Integrated Distribution Strategies 6/12/2025

    Discover the power of integrated distribution for cell and gene therapies. Learn from expert speakers how adaptable partnerships can successfully bring these innovative treatments to more patients.

  3. The Hidden Risk In Cell & Gene Therapy Commercialization 6/5/2025

    Of the root causes of new product launch failure, insufficient relative advantage is by far the most important. Let's take a closer look at lessons we can learn from two key (approved) cell therapies.

  4. A Road Map For Transitioning From A Research-Focused To Commercialization Mindset 6/3/2025

    As the timeline for commercialization closes in, it’s necessary to best position the organization for a successful launch. Where to start?

  5. Accelerating Cell Therapy Development, Manufacturing Workflows 5/30/2025

    Realizing the full potential of modern cell therapies requires optimizing every stage of the process. Explore how advanced solutions can accelerate your development and manufacturing pipeline.

  6. Combining Best-Of-Breed Tech And Services To Ensure Commercial Success 5/29/2025

    Current "end-to-end" automation often forces sacrifices in cell therapy manufacturing, but a strategy integrating specialized technologies for key bottlenecks is now aiming to improve efficiency.

  7. Navigating Regulatory Complexity In CGT Development, Commercialization 5/28/2025

    To successfully commercialize cell and gene therapies, understanding evolving US regulatory mandates is key. Consider these strategies to avoid delays and ensure compliance.

  8. Why Better Manufacturing Is the Key to Unlocking Cell Therapy's Full Potential 5/22/2025

    Emerging technologies are beginning to address the complex manufacturing challenges that have limited the scalability and accessibility of CAR-T and other cell therapies.

  9. 3 Strategies For A Successful Journey Toward Cell And Gene Therapy Commercialization 5/13/2025

    CTMC's Amy Hay provides 3 recommendations for teams developing cell and gene therapies, from clinical research through commercialization.

  10. Gene Therapy Solutions: From Discovery To Commercialization 5/7/2025

    Learn how advanced technologies and methodologies are driving progress in gene therapy, enabling safer and more effective treatments for rare and complex diseases.